Subscribe

News
Academy
Multimedia
Conferences
Publications
Partner Perspectives
Resources
Subscribe

|Articles|April 15, 2016

Episode 2: How On-Dose Technologies Mitigate Safety Risks and Reduce Product Diversion and Counterfeiting

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Related Content

Stock.adobe.com

EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval

June 26th 2026

Kirsten Whipple

The New Healthy Aging Imperative and What It Means for Pharma

ByKirsten Whipple

June 26th 2026

Jessica Dunne, US Medical, Autoimmune Diabetes Medical Director at Sanofi

Reading Between the Lines: Closing the T1D Misdiagnosis Gap

ByJessica Dunne

June 26th 2026

Pharmaceutical Executive Daily

Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer

June 25th 2026

Beyond the Strip: Las Vegas Has a New Kind of Venture in Mind

ByJoe Petroziello

June 25th 2026

Trending on PharmExec

EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval

Reading Between the Lines: Closing the T1D Misdiagnosis Gap

The New Healthy Aging Imperative and What It Means for Pharma

FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer

The Rise of Direct-to-Patient Models in Pharma: Opportunities and Risks in Bypassing Traditional Distribution Channels